Feedback
European Shorting
My Portfolios
Browse Gurus
Print
Email
Mednax, Inc. has a market cap of $3.06 billion; its shares were traded at around $64.19 with a P/E ratio of 16.4 and P/S ratio of 2.4. Mednax, Inc. had an annual average earning growth of 18.6% over the past 10 years. GuruFocus rated Mednax, Inc. the business predictability rank of 5-star.
MD is in the portfolios of Andreas Halvorsen of Viking Global Investors LP, David Dreman of Dreman Value Management, Columbia Wanger of Columbia Wanger Asset Management, Richard Pzena of Pzena Investment Management LLC, Chuck Royce of Royce& Associates, Jeremy Grantham of GMO LLC, George Soros of Soros Fund Management LLC, Steven Cohen of SAC Capital Advisors.
CFO Recent Trades:
- Sell: CFO Vivian Lopez-blanco sold 1,850 shares of MD stock on 11/04/2010 at the average price of 61.5. Vivian Lopez-blanco owns at least 19,395 shares after this. The price of the stock has increased by 4.37% since.
This is the insider trade history vs. stock price of MD. For the complete insider trading history of MD, click here.
Directors and Officers Recent Trades:
- Sell: COO / Pediatrix Division David A. Clark sold 2,960 shares of MD stock on 12/02/2010 at the average price of 64.72. David A. Clark owns at least 17,528 shares after this. The price of the stock has decreased by 0.82% since.
Subscribe RSS
RSS